Blockers of Skeletal Muscle Nav1.4 Channels: From Therapy of Myotonic Syndrome to Molecular Determinants of Pharmacological Action and Back
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24010857 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Michela De Bellis und 4 weiteren Autor:innen. Beteiligte Einrichtung: Section of Pharmacology, Department of Pharmacy-Drug Sciences, University of Bari "Aldo Moro", 70125 Bari, Italy. Hauptthemen laut MEDLINE: Mexiletine, Myotonia, NAV1.4 Voltage-Gated Sodium Channel, Voltage-Gated Sodium Channel Blockers. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: PRIN 2017, Ateneo Uniba, PRIN.
Abstract (Originalsprache)
The voltage-gated sodium channels represent an important target for drug discovery since a large number of physiological processes are regulated by these channels. In several excitability disorders, including epilepsy, cardiac arrhythmias, chronic pain, and non-dystrophic myotonia, blockers of voltage-gated sodium channels are clinically used. Myotonia is a skeletal muscle condition characterized by the over-excitability of the sarcolemma, resulting in delayed relaxation after contraction and muscle stiffness. The therapeutic management of this disorder relies on mexiletine and other sodium channel blockers, which are not selective for the Nav1.4 skeletal muscle sodium channel isoform. Hence, the importance of deepening the knowledge of molecular requirements for developing more potent and use-dependent drugs acting on Nav1.4. Here, we review the available treatment options for non-dystrophic myotonia and the structure–activity relationship studies performed in our laboratory with a focus on new compounds with potential antimyotonic activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Pharmacology, Department of Pharmacy-Drug Sciences, University of Bari "Aldo Moro", 70125 Bari, Italy.
ORCID-Profile: Brigida Boccanegra, Paola Imbrici, Annamaria De Luca
Förderung
- PRIN 2017
- Ateneo Uniba
- PRIN
- Fondi Ateneo Uniba
Zitieren
APA
De Bellis, M., Boccanegra, B., Cerchiara, A. G., Imbrici, P., & De Luca, A. (2023). Blockers of Skeletal Muscle Nav1.4 Channels: From Therapy of Myotonic Syndrome to Molecular Determinants of Pharmacological Action and Back. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24010857
Vancouver
De Bellis M, Boccanegra B, Cerchiara AG, Imbrici P, De Luca A. Blockers of Skeletal Muscle Nav1.4 Channels: From Therapy of Myotonic Syndrome to Molecular Determinants of Pharmacological Action and Back. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24010857
BibTeX
@article{DeBellis2023,
author = {De Bellis, Michela and Boccanegra, Brigida and Cerchiara, Alessandro Giovanni and Imbrici, Paola and De Luca, Annamaria},
title = {Blockers of Skeletal Muscle Nav1.4 Channels: From Therapy of Myotonic Syndrome to Molecular Determinants of Pharmacological Action and Back},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24010857}
}
EUVIMED